Search Results - Hosbach, Jennifer

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor

    A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor by Emanuel, Stuart L., Engle, Linda J., Chao, Ginger, Zhu, Rong-Rong, Cao, Carolyn, Lin, Zheng, Yamniuk, Aaron P., Hosbach, Jennifer, Brown, Jennifer, Fitzpatrick, Elizabeth, Gokemeijer, Jochem, Morin, Paul, Morse, Brent A., Carvajal, Irvith M., Fabrizio, David, Wright, Martin C., Das Gupta, Ruchira, Gosselin, Michael, Cataldo, Daniel, Ryseck, Rolf P., Doyle, Michael L., Wong, Tai W., Camphausen, Raymond T., Cload, Sharon T., Marsh, H. Nicholas, Gottardis, Marco M., Furfine, Eric S.

    Published in mAbs
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Abstract 2134: Niraparib combined with abiraterone acetate inhibits the growth of BRCA2wt prostate tumors

    Abstract 2134: Niraparib combined with abiraterone acetate inhibits the growth of BRCA2wt prostate tumors by Damle, Rajendra N., Hawkins, Rebecca, Hosbach, Jennifer, Ndikuyeze, Georges Habineza, Driscoll, Jenny, Fulton, Natalie L., Derosa, David, Hughes, Anna, Chu, Gerald, Calara-Nielsen, Karl, Smirnov, Denis, Shen, Dong, Snyder, Linda A.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Abstract DDT01-03: Discovery of BMS-911543, a highly selective JAK2 inhibitor, as a clinical candidate for the treatment of myeloproliferative disease and other malignancies

    Abstract DDT01-03: Discovery of BMS-911543, a highly selective JAK2 inhibitor, as a clinical candidate for the treatment of myeloproliferative disease and other malignancies by Purandare, Ashok V., Wan, Honghe, Schroeder, Gretchen, Hart, Amy, Grebinski, James, Inghrim, Jennifer, Tokarski, John, You, Dan, Penhallow, Becky, McDevitt, Theresa, Vuppugalla, Ragini, Zhang, Yueping, Ruepp, Stefan, Trainor, George, Han, Xia, Lombardo, Louis, Lee, Francis Y., Gottardis, Marco, Hosbach, Jennifer, Fitzpatrick, Elizabeth, Emanuel, Stuart, Pardanani, Animesh, Lasho, Terra L., Tefferi, Ayalew, Lorenzi, Matthew V.

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Abstract 2586: Adnectins as a platform for multi-specific targeted biologics: A novel bispecific inhibitor of EGFR and IGF-IR growth factor receptors

    Abstract 2586: Adnectins as a platform for multi-specific targeted biologics: A novel bispecific inhibitor of EGFR and IGF-IR growth factor receptors by Emanuel, Stuart L., Engle, Linda J., Cao, Carolyn, Chao, Ginger, Lin, Zheng, Zhu, Rong-Rong, Yamniuk, Aaron P., Hosbach, Jennifer, Brown, Jennifer, Fitzpatrick, Elizabeth, Gokemeijer, Jochem, Morin, Paul, Morse, Brent, Carvajal, Irvith, Fabrizio, David, Wright, Martin, DasGupta, Ruchira, Gosselin, Mike, Ryseck, Rolf, Doyle, Michael L., Wong, Tai W., Camphausen, Ray, Cload, Sharon T., Marsh, Nick, Furfine, Eric S., Gottardis, Marco M.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: